ScholarIQanswers from OpenAlex
Cameroon Baptist Convention Health Services
InstitutionResearch output, impact & collaborations
Cameroon Baptist Convention Health Services is a institution indexed in ScholarIQ from OpenAlex.
What is known about Cameroon Baptist Convention Health Services?
ScholarIQrecord summary
Cameroon Baptist Convention Health Services is a research organisation in Bamenda, CM. OpenAlex records 602 works and 19,878 citations for it. 405 researchers list it as their most recent affiliation.
How many works does Cameroon Baptist Convention Health Services have?
ScholarIQindexed works
Cameroon Baptist Convention Health Services has 602 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Cameroon Baptist Convention Health Services have?
ScholarIQcitation count
Cameroon Baptist Convention Health Services has 19,878 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Cameroon Baptist Convention Health Services?
ScholarIQresearcher count
Cameroon Baptist Convention Health Services has 405 researchers in the ScholarIQ index.
What is the average h-index at Cameroon Baptist Convention Health Services?
ScholarIQavg h-index
Cameroon Baptist Convention Health Services has an average h-index of 22 in OpenAlex.
What is the ROR of Cameroon Baptist Convention Health Services?
ScholarIQror
The ROR for Cameroon Baptist Convention Health Services is on the source record.
What is the OpenAlex record for Cameroon Baptist Convention Health Services?
ScholarIQopenalex
The OpenAlex for Cameroon Baptist Convention Health Services is on the source record.
Who are the most-cited researchers behind Cameroon Baptist Convention Health Services?
ScholarIQtop researchers by citations
What are the most-cited papers on Cameroon Baptist Convention Health Services?
ScholarIQmost cited works
Follow-up after primary therapy for endometrial cancer: A systematic review
Michael Fung‐Kee‐Fung, Jason Dodge, Laurie Elit, Himu Lukka, Alex Chambers, Tom Oliver
Phase II Study of Temsirolimus in Women With Recurrent or Metastatic Endometrial Cancer: A Trial of the NCIC Clinical Trials Group
Amit M. Oza, Laurie Elit, Ming‐Sound Tsao, Suzanne Kamel‐Reid, Jim Biagi, Diane Provencher, Walter H. Gotlieb, Paul Hoskins, Prafull Ghatage, Katia Tonkin, Helen Mackay, J. Mazurka, Joana Sederias, Percy Ivy, Janet Dancey, Elizabeth A. Eisenhauer
Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials
Ignace Vergote, Corneel Coens, Matthew Nankivell, Gunnar B. Kristensen, Mahesh Parmar, Tom Ehlen, Gordon C. Jayson, Nick Johnson, Ann Marie Swart, René H.M. Verheijen, W. Glenn McCluggage, Timothy Perren, Pierluigi Benedetti Panici, Gemma G. Kenter, Antonio Casado, César Mendiola, Gavin Stuart, N.S. Reed, Sean Kehoe, Claes Tropé G., Stephen Dobbs, Sharadah Essapen, P. Hoskins, John Green, Edward D. Gilby, Marchien van Baal, Jeremy Twigg, Maria E.L. van der Burg, Keith Godfrey, Ángel J. Lacave, Roberto Angioli, Rahul Nath, K. Chin, Charles Redman, Robert Lotocki, Adeola Olaitan, Berit Jul Mosgaard, Gordon Rustin, Thomas Ind, Mojca Persic, Martin Hogg, Jacobus van der Velden, Jonathan A. Ledermann, Peter Sykes Peter Sykes, Krishnawam Madhavan, Päivi Kannisto, V Hird, Anthony C. Evans, R. Sandvei R., Philippe Gauthier, Derek Cruickshank, P.B. Ottevanger, Sheila E. Pearson, Henry C Kitchener, Marcia Hall, Paul Bessette, S. Pecorelli, Eva Gerdin, Tito Lopes, Andrew Fish, Clare Barlow, Koen Van Eygen, Anne Floquet, Bengt Tholander, Nurdan Gül, Robert Gornall, David Luesley, P. H. Kirwan, Paul Symonds, Richard Henry, David Poole, Ian McNeish, M A Hocking, Al Sammaraie, P Speiser, Éric Leblanc, J.A. Green, C Fernández Oliveira, Robert Grimshaw, Paolo Zola, David E. Parkin, David Luesley, Martin Lamb, Anne Hong, Alan Gillespie, Abdel Hamid, Ahmed Ahmed, Marie Plante, B. De Valk, A Nordin, Andrew R. Clamp, D Díaz Pérez, Graham Dark, Michelle Ferguson, Carol MacGregor, G. Skailes, Rachel Jones, Alan Gillespie, G. Cawdell, Simon Leeson
Optimal Chemotherapy Treatment for Women with Recurrent Ovarian Cancer
Michael Fung‐Kee‐Fung, Thomas R. Oliver, Laurie Elit, Amit M. Oza, Hal W. Hirte, Peter Bryson, on behalf of the Gynecology Cancer Disease Site Group of Cancer Care Ontario’s Program in Evidence-Based Care
The impact of prophylactic salpingo-oophorectomy on menopausal symptoms and sexual function in women who carry a BRCA mutation
Amy Finch, Kelly Metcalfe, Jaclyn Chiang, Laurie Elit, J. McLaughlin, C. Springate, Rochelle Demsky, Joan Murphy, Barry P. Rosen, Steven A. Narod
How much of the research on Cameroon Baptist Convention Health Services is open access?
ScholarIQopen access share
67%OPEN ACCESS